Interferon-γ is a master checkpoint regulator of cytokine-induced differentiation

Proceedings of the National Academy of Sciences of the United States of America

Volumn 114, Issue 33, 2017, Pages E6867-E6874

  Zha, Zhao ^a   Bucher, Felicitas ^a   Nejatfard, Anahita ^a   Zheng, Tianqing ^a   Zhang, Hongkai ^a   Yea, Kyungmoo ^a   Lerner, Richard A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Checkpoint; Cytokine; Differentiation; Interferon ; Master regulator

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; GAMMA INTERFERON; GLYCOPROTEIN GP 130; ALKALINE PHOSPHATASE; ONCOSTATIN M; STAT1 PROTEIN; STAT1 PROTEIN, HUMAN;

ARTICLE; CELL DIFFERENTIATION; INTERNALIZATION; MOLECULAR LIBRARY; ODONTOBLAST; PRIORITY JOURNAL; CELL CULTURE; CYTOLOGY; DRUG EFFECT; HEK293 CELL LINE; HUMAN; METABOLISM; SCANNING ELECTRON MICROSCOPY; STEM CELL; TOOTH PULP; U-937 CELL LINE; ULTRASTRUCTURE;

ALKALINE PHOSPHATASE; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINE RECEPTOR GP130; CYTOKINES; DENTAL PULP; HEK293 CELLS; HUMANS; INTERFERON-GAMMA; MICROSCOPY, ELECTRON, SCANNING; ONCOSTATIN M; STAT1 TRANSCRIPTION FACTOR; STEM CELLS; U937 CELLS;

EID: 85027409839     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1706915114     Document Type: Article

References (40)

1. Germain RN (2012) Maintaining system homeostasis: The third law of Newtonian immunology. Nat Immunol 13:902–906.
2. Mellman I, Coukos G, Dranoff G (2011) Cancer immunotherapy comes of age. Nature 480:480–489.
3. Dong Y, Sun Q, Zhang X (2017) PD-1 and its ligands are important immune checkpoints in cancer. Oncotarget 8:2171–2186.
4. Bezbradica JS, Medzhitov R (2009) Integration of cytokine and heterologous receptor signaling pathways. Nat Immunol 10:333–339.
5. Xie J, Zhang H, Yea K, Lerner RA (2013) Autocrine signaling based selection of combinatorial antibodies that transdifferentiate human stem cells. Proc Natl Acad Sci USA 110:8099–8104.
6. Yea K, et al. (2013) Converting stem cells to dendritic cells by agonist antibodies from unbiased morphogenic selections. Proc Natl Acad Sci USA 110:14966–14971.
7. Baxter GT, Kuo RC, Jupp OJ, Vandenabeele P, MacEwan DJ (1999) Tumor necrosis factor-alpha mediates both apoptotic cell death and cell proliferation in a human hematopoietic cell line dependent on mitotic activity and receptor subtype expression. J Biol Chem 274:9539–9547.
8. Baud V, Karin M (2001) Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 11:372–377.
9. Dunne A, O’Neill LA (2003) The interleukin-1 receptor/Toll-like receptor superfamily: Signal transduction during inflammation and host defense. Sci STKE 2003:re3.
10. Yamamoto A, Sakai K, Matsubara K, Kano F, Ueda M (2014) Multifaceted neuroregenerative activities of human dental pulp stem cells for functional recovery after spinal cord injury. Neurosci Res 78:16–20.
11. Gandia C, et al. (2008) Human dental pulp stem cells improve left ventricular function, induce angiogenesis, and reduce infarct size in rats with acute myocardial infarction. Stem Cells 26:638–645.
12. Akkouch A, Zhang Z, Rouabhia M (2014) Engineering bone tissue using human dental pulp stem cells and an osteogenic collagen-hydroxyapatite-poly (L-lactide-co-ε-caprolactone) scaffold. J Biomater Appl 28:922–936.
13. + stem cells with stromal cell-derived factor-1. Tissue Eng Part A 17:1911–1920.
14. Wozney JM, et al. (1988) Novel regulators of bone formation: Molecular clones and activities. Science 242:1528–1534.
15. Bravo J, Heath JK (2000) Receptor recognition by gp130 cytokines. EMBO J 19: 2399–2411.
16. Tanaka M, et al. (1999) Reconstitution of the functional mouse oncostatin M (OSM) receptor: Molecular cloning of the mouse OSM receptor beta subunit. Blood 93: 804–815.
17. Karsenty G, Kronenberg HM, Settembre C (2009) Genetic control of bone formation. Annu Rev Cell Dev Biol 25:629–648.
18. Brodsky B, Baum J (2008) Structural biology: Modelling collagen diseases. Nature 453: 998–999.
19. Merry K, Dodds R, Littlewood A, Gowen M (1993) Expression of osteopontin mRNA by osteoclasts and osteoblasts in modelling adult human bone. J Cell Sci 104:1013–1020.
20. Parkin J, Cohen B (2001) An overview of the immune system. Lancet 357:1777–1789.
21. Calò V, et al. (2003) STAT proteins: From normal control of cellular events to tumorigenesis. J Cell Physiol 197:157–168.
22. Gil MP, et al. (2001) Biologic consequences of Stat1-independent IFN signaling. Proc Natl Acad Sci USA 98:6680–6685.
23. Kim S, et al. (2003) Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation. Genes Dev 17:1979–1991.
24. Hu X, Ivashkiv LB (2009) Cross-regulation of signaling pathways by interferon-gamma: Implications for immune responses and autoimmune diseases. Immunity 31:539–550.
25. Auguste P, et al. (1997) Signaling of type II oncostatin M receptor. J Biol Chem 272: 15760–15764.
26. Hibi M, et al. (1990) Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 63:1149–1157.
27. Wang Y, Fuller GM (1994) Phosphorylation and internalization of gp130 occur after IL-6 activation of Jak2 kinase in hepatocytes. Mol Biol Cell 5:819–828.
28. Honke N, et al. (2014) The p38-mediated rapid down-regulation of cell surface gp130 expression impairs interleukin-6 signaling in the synovial fluid of juvenile idiopathic arthritis patients. Arthritis Rheumatol 66:470–478.
29. Gibson RM, et al. (2000) Phosphorylation of human gp130 at Ser-782 adjacent to the di-leucine internalization motif. Effects on expression and signaling. J Biol Chem 275: 22574–22582.
30. Scaffidi AK, et al. (2002) Oncostatin M stimulates proliferation, induces collagen production and inhibits apoptosis of human lung fibroblasts. Br J Pharmacol 136: 793–801.
31. Canady J, Arndt S, Karrer S, Bosserhoff AK (2013) Increased KGF expression promotes fibroblast activation in a double paracrine manner resulting in cutaneous fibrosis. J Invest Dermatol 133:647–657.
32. Gronthos S, Mankani M, Brahim J, Robey PG, Shi S (2000) Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci USA 97:13625–13630.
33. Ferro F, et al. (2012) Dental pulp stem cells differentiation reveals new insights in Oct4A dynamics. PLoS One 7:e41774.
34. Zhou Y, et al. (2011) Effects of leukemia inhibitory factor on proliferation and odontoblastic differentiation of human dental pulp cells. J Endod 37:819–824.
35. Cheon H, Stark GR (2009) Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes. Proc Natl Acad Sci USA 106:9373–9378.
36. Meyer T, Begitt A, Lödige I, van Rossum M, Vinkemeier U (2002) Constitutive and IFN-gamma-induced nuclear import of STAT1 proceed through independent pathways. EMBO J 21:344–354.
37. Meyer T, Gavenis K, Vinkemeier U (2002) Cell type-specific and tyrosine phosphorylation-independent nuclear presence of STAT1 and STAT3. Exp Cell Res 272:45–55.
38. Yang J, Stark GR (2008) Roles of unphosphorylated STATs in signaling. Cell Res 18: 443–451.
39. Duque G, et al. (2009) Autocrine regulation of interferon gamma in mesenchymal stem cells plays a role in early osteoblastogenesis. Stem Cells 27:550–558.
40. Liu Y, et al. (2011) Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-γ and TNF-α. Nat Med 17:1594–1601.